Teva Pharmaceutical Industries Reports Insider Sales of 58,295 Shares on August 1.

Teva Pharmaceutical Industries Ltd. has announced that Eric A. Hughes has sold 52,742 shares at $15.16 per share on August 1, 2025, and Placid Jover has sold 6,053 shares at $15.16 per share on the same day.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has reported insider sales of shares by two executives. On August 1, 2025, Eric A. Hughes sold 52,742 shares at $15.16 per share, while Placid Jover sold 6,053 shares at the same price. The total market value of the shares sold by Hughes is approximately $801,212, and by Jover, it is around $91,748. These sales are part of a routine compliance with Rule 144, which requires a two-year holding period for restricted-share units [1].

The aggregate value of the shares sold by Hughes and Jover is trivial compared to Teva's market capitalization of $17.64 billion and the total share count of over 1 billion. The insider sales, therefore, are unlikely to have a significant impact on the company's liquidity, earnings per share (EPS), or strategic direction. However, the planned sales can be perceived negatively by some investors who track management sentiment [1].

Teva's stock has recently received multiple buy ratings from research firms, with a consensus target price of $24.71, reflecting positive expectations for the company’s future performance. Despite the insider sales, the overall investment thesis for Teva remains unchanged. The company's recent earnings report showed a positive return on equity of 46.10% and a negative net margin of 0.95% [2].

Institutional investors have also shown interest in Teva, with several large investors increasing their stakes in the company. King Wealth Management Group, for instance, increased its holdings by 1,106.9% in the first quarter, acquiring an additional 160,500 shares. Other notable investors include American Century Companies Inc., Blair William & Co. IL, Norges Bank, Pictet Asset Management Holding SA, and Orion Portfolio Solutions LLC [2].

References:
[1] https://www.stocktitan.net/sec-filings/NET/144-cloudflare-inc-class-a-common-stock-par-value-0-001-per-share-sec-f4a937bf0f49.html
[2] https://www.marketbeat.com/instant-alerts/filing-teva-pharmaceutical-industries-ltd-nyseteva-shares-purchased-by-king-wealth-management-group-2025-07-31/